EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The impact of Gam-COVID-Vac, an Adv5/Adv26 COVID-19 vaccine, on the biomarkers of endothelial function, coagulation and platelet activation

Anar Turmukhambetova iD, Sergey Yegorov iD, Ilya Korshukov iD, Valentina Barkhanskaya iD, Svetlana Kolesnichenko iD, Dmitriy Klyuyev iD, Zhibek Zhumadilova iD, Aruzhan Pralieva, Laylim Absaghit, Ruslan Belyaev iD, Dmitriy Babenko, Gonzalo H Hortelano und 3 weitere

PLOS ONE · 2023

DOI: 10.1371/journal.pone.0293074 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, 2023. Verfasst von Anar Turmukhambetova und 14 weiteren Autor:innen. Beteiligte Einrichtung: Research Centre, Karaganda Medical University, Karaganda, Kazakhstan. Hauptthemen laut MEDLINE: COVID-19 Vaccines, COVID-19. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Healthcare of the Republic of Kazakhstan.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

COVID-19 vaccines have played a critical role in controlling the COVID-19 pandemic. Although overall considered safe, COVID-19 vaccination has been associated with rare but severe thrombotic events, occurring mainly in the context of adenoviral vectored vaccines. A better understanding of mechanisms underlying vaccine-induced hypercoagulability and prothrombotic state is needed to improve vaccine safety profile. We assessed changes to the biomarkers of endothelial function (endothelin, ET-1), coagulation (thrombomodulin, THBD and plasminogen activator inhibitor, PAI) and platelet activation (platelet activating factor, PAF, and platelet factor 4 IgG antibody, PF4 IgG) within a three-week period after the first (prime) and second (boost) doses of Gam-Covid-Vac, an AdV5/AdV26-vectored COVID-19 vaccine. Blood plasma collected from vaccinees (n = 58) was assayed using ELISA assays. Participants were stratified by prior COVID-19 exposure based on their baseline SARS-CoV-2-specific serology results. We observed a significant post-prime increase in circulating ET-1, with levels sustained after the boost dose compared to baseline. ET-1 elevation following dose 2 was most pronounced in vaccinees without prior COVID-19 exposure. Prior COVID-19 was also associated with a mild increase in post-dose 1 PAI. Vaccination was associated with elevated ET-1 up to day 21 after the second vaccine dose, while no marked alterations to other biomarkers, including PF4 IgG, were seen. A role of persistent endothelial activation following COVID-19 vaccination warrants further investigation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19 VaccinesCOVID-19HumansPandemicsSARS-CoV-2Platelet ActivationBiomarkersImmunoglobulin GPlatelet Factor 4Antibodies, Viral

Substanzen

COVID-19 VaccinesBiomarkersImmunoglobulin GPlatelet Factor 4Antibodies, Viral

Autor:innen und Institutionen

  • Research Centre, Karaganda Medical University, Karaganda, Kazakhstan.
  • Michael G. DeGroote Institute for Infectious Disease Research, McMaster Immunology Research Centre, Department of Biochemistry and Biomedical Sciences, McMaster University, Hamilton, ON, Canada.
  • School of Sciences and Humanities, Nazarbayev University, Astana, Kazakhstan.
  • Department of Neurology, Psychiatry and Rehabilitology, Karaganda, Kazakhstan.

ORCID-Profile: Anar Turmukhambetova, Sergey Yegorov, Ilya Korshukov, Valentina Barkhanskaya, Svetlana Kolesnichenko, Dmitriy Klyuyev, Zhibek Zhumadilova, Ruslan Belyaev, Matthew S Miller, Irina Kadyrova

Förderung

  • Ministry of Healthcare of the Republic of Kazakhstan

Zitieren

APA

Turmukhambetova, A., Yegorov, S., Korshukov, I., Barkhanskaya, V., Kolesnichenko, S., Klyuyev, D., Zhumadilova, Z., Pralieva, A., Absaghit, L., Belyaev, R., Babenko, D., Hortelano, G. H., Miller, M. S., Vazenmiller, D., & Kadyrova, I. (2023). The impact of Gam-COVID-Vac, an Adv5/Adv26 COVID-19 vaccine, on the biomarkers of endothelial function, coagulation and platelet activation. PLOS ONE. https://doi.org/10.1371/journal.pone.0293074

Vancouver

Turmukhambetova A, Yegorov S, Korshukov I, Barkhanskaya V, Kolesnichenko S, Klyuyev D, et al. The impact of Gam-COVID-Vac, an Adv5/Adv26 COVID-19 vaccine, on the biomarkers of endothelial function, coagulation and platelet activation. PLOS ONE. 2023. doi:10.1371/journal.pone.0293074

BibTeX
@article{Turmukhambetova2023,
  author = {Turmukhambetova, Anar and Yegorov, Sergey and Korshukov, Ilya and Barkhanskaya, Valentina and Kolesnichenko, Svetlana and Klyuyev, Dmitriy and Zhumadilova, Zhibek and Pralieva, Aruzhan and Absaghit, Laylim and Belyaev, Ruslan and Babenko, Dmitriy and Hortelano, Gonzalo H and Miller, Matthew S and Vazenmiller, Dmitriy and Kadyrova, Irina},
  title = {The impact of Gam-COVID-Vac, an Adv5/Adv26 COVID-19 vaccine, on the biomarkers of endothelial function, coagulation and platelet activation},
  journal = {PLOS ONE},
  year = {2023},
  doi = {10.1371/journal.pone.0293074}
}
Kostenlos starten →